miRSNP-based approach identifies a miRNA that regulates prostate-specific antigen in an allele-specific manner

Cancer Discovery

Volumn 5, Issue 4, 2015, Pages 351-352

  Yousef, George M ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; KALLIKREIN; MICRORNA; PROSTATE SPECIFIC ANTIGEN; MESSENGER RNA;

ARTICLE; CANCER RISK; GENE; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; MIRNA TARGET GENE; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; BINDING SITE; GENETICS; MALE; PROSTATE TUMOR;

BINDING SITES; GENETIC VARIATION; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 84939491854     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-15-0230     Document Type: Article

References (10)

1. Manolio TA. Bringing genome-wide association findings into clinical use. Nat Rev Genet 2013; 14: 549-58.
2. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009; 106: 9362-7.
3. Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet 2013; 14: 483-95.
4. Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin H-Y, et al. A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer. Cancer Discov 2015;5:368-79.
5. Liu C, Zhang F, Li T, Lu M, Wang L, Yue W, et al. MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics 2012; 13: 661.
6. Bryant RJ, Lilja H. Emerging PSA-based tests to improve screening. Urol Clin North Am 2014; 41: 267-76.
7. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013; 45: 385-91, 391e381-2.
8. Lichner Z, Fendler A, Saleh C, Nasser AN, Boles D, Al-Haddad S, et al. MicroRNA signature helps distinguish early from late biochemical failure in prostate cancer. Clin Chem 2013; 59: 1595-603.
9. White NM, Youssef YM, Fendler A, Stephan C, Jung K, Yousef GM. The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer. Biol Chem 2012; 393: 379-89.
10. Samaan S, Lichner Z, Ding Q, Saleh C, Samuel J, Streutker C, et al. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression. Biol Chem 2014; 395: 991-1001.